Fact CheckerSign in

NCT06301295Active, not recruiting

Feasibility of Targeted Bronchial Washing for Molecular Testing by Next Generation Sequencing in Early-stage Lung Cancer

Feasibility of Targeted Bronchial Washing Fluid for Molecular Testing With Next Generation Sequencing in Patients With Early-stage Non-small Cell Lung Cancer

Source: ClinicalTrials.gov · Last updated 11 Mar 2026

Brief summary (registry, in English)

This is a single center, clinical trial evaluating the relevance of intratumoral washing for detection of generic alteration with Next Generation Sequencing.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
3 Mar 2024
Start date
29 May 2024
Primary completion date
31 Dec 2025
Lead sponsor
Pusan National University Hospital
Diseases
Lung cancer
NCT number
NCT06301295

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 29 May 2024 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Inclusion Criteria:
    • Age ≥ 20 years
    • Obtained written informed consent
    • Subjects suspected of having resectable lung cancer on computed tomography
    • Subjects without contraindication to brochoscopy
    • Subjects planning to undergo surgery for suspected lung cancer and opting for tissue or liquid biopsy for genetic alteration using Next Generation Sequencing
  • Exclusion Criteria:
    • Subjects who withdraw informed consent
    • Subjects who are unable to undergo liquid biopsy (plasma) and tissue biopsy - for genetic alteration with Next Generation Sequencing based on the investigator's judgement
    • Subjects diagnosed with a cancer other than non-small cell lung cancer from the lung tissue lesion
    • Subjects diagnosed with a benign lesion from the lung tissue lesion

Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Pusan National University Hospital
Coordinator of this site? Confirm its status
BusanSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.